ARID1A Downregulation Predicts High PD-L1 Expression and Worse Clinical Outcome in Patients With Gallbladder Cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Lingxi,Nan ^[1] ; Changcheng,Wang ^[2] ; Jie,Wang ^[3] ; Shulong,Zhang ^[1] ; Xiaobo,Bo ^[2] ; Yueqi,Wang ^[3] ; Houbao,Liu ^[4]

作者单位： Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. ^[1] Biliary Tract Diseases Institute, Fudan University, Shanghai, China. ^[2] Shanghai Engineering Research Center of Biliary Tract Minimal Invasive Surgery and Materials, Shanghai, China. ^[3] Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. ^[4] Department of General Surgery, Xuhui District Central Hospital, Shanghai, China. ^[5] Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China. ^[6]

关键词 ARID1A PD-L1 PD1 gallbladder cancer prognosis tumor immune

DOI 10.3389/fonc.2022.787897

PMID 35198440

发布时间 2022-05-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2022年12卷

787897页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

ARID1A Downregulation Predicts High PD-L1 Expression and Worse Clinical Outcome in Patients With Gallbladder Cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

ARID1A Downregulation Predicts High PD-L1 Expression and Worse Clinical Outcome in Patients With Gallbladder Cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除